25 XP   0   0   10

Sigma Pharmaceuticals Ltd
Buy, Hold or Sell?

Let's analyse Sigma Pharmaceuticals Ltd together

PenkeI guess you are interested in Sigma Pharmaceuticals Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Sigma Pharmaceuticals Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Sigma Pharmaceuticals Ltd

I send you an email if I find something interesting about Sigma Pharmaceuticals Ltd.

Quick analysis of Sigma Pharmaceuticals Ltd (30 sec.)










What can you expect buying and holding a share of Sigma Pharmaceuticals Ltd? (30 sec.)

How much money do you get?

How much money do you get?
A$0.02
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
A$0.53
Expected worth in 1 year
A$1.50
How sure are you?
80.0%

+ What do you gain per year?

Total Gains per Share
A$0.99
Return On Investment
77.8%

For what price can you sell your share?

Current Price per Share
A$1.28
Expected price per share
A$1.0559 - A$1.3275
How sure are you?
50%

1. Valuation of Sigma Pharmaceuticals Ltd (5 min.)




Live pricePrice per Share (EOD)

A$1.28

Intrinsic Value Per Share

A$0.00 - A$0.86

Total Value Per Share

A$0.54 - A$1.39

2. Growth of Sigma Pharmaceuticals Ltd (5 min.)




Is Sigma Pharmaceuticals Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$560.4m$306.8m$253.6m45.2%

How much money is Sigma Pharmaceuticals Ltd making?

Current yearPrevious yearGrowGrow %
Making money$2.8m$1.1m$1.7m59.8%
Net Profit Margin0.1%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Sigma Pharmaceuticals Ltd (5 min.)




4. Comparing to competitors in the Medical Distribution industry (5 min.)




  Industry Rankings (Medical Distribution)  


Richest
#17 / 40

Most Revenue
#14 / 40

Most Profit
#25 / 40

What can you expect buying and holding a share of Sigma Pharmaceuticals Ltd? (5 min.)

Welcome investor! Sigma Pharmaceuticals Ltd's management wants to use your money to grow the business. In return you get a share of Sigma Pharmaceuticals Ltd.

What can you expect buying and holding a share of Sigma Pharmaceuticals Ltd?

First you should know what it really means to hold a share of Sigma Pharmaceuticals Ltd. And how you can make/lose money.

Speculation

The Price per Share of Sigma Pharmaceuticals Ltd is A$1.275. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Sigma Pharmaceuticals Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Sigma Pharmaceuticals Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.53. Based on the TTM, the Book Value Change Per Share is A$0.24 per quarter. Based on the YOY, the Book Value Change Per Share is A$-0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.01 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Sigma Pharmaceuticals Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps0.000.1%0.000.1%0.000.1%0.000.3%0.010.9%
Usd Book Value Change Per Share0.1612.2%0.1612.2%0.00-0.3%0.032.2%0.010.9%
Usd Dividend Per Share0.000.3%0.000.3%0.010.5%0.010.5%0.010.9%
Usd Total Gains Per Share0.1612.5%0.1612.5%0.000.2%0.032.7%0.021.8%
Usd Price Per Share0.66-0.66-0.40-0.43-0.48-
Price to Earnings Ratio374.58-374.58-555.16-154.35-90.65-
Price-to-Total Gains Ratio4.17-4.17-204.02--6.06-20.38-
Price to Book Ratio1.94-1.94-2.10-1.90-2.20-
Price-to-Total Gains Ratio4.17-4.17-204.02--6.06-20.38-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.8189325
Number of shares1221
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.01
Usd Book Value Change Per Share0.160.03
Usd Total Gains Per Share0.160.03
Gains per Quarter (1221 shares)194.5541.95
Gains per Year (1221 shares)778.21167.81
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
11975976830138158
2381518154660276326
3582277232490413494
47730363102120551662
59637953880150689830
611545544658180827998
7134531354362109641166
81536072621424011021334
91736831699227012401502
101927590777030013781670

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%2.01.00.066.7%3.02.00.060.0%8.02.00.080.0%21.04.00.084.0%
Book Value Change Per Share1.00.00.0100.0%1.02.00.033.3%2.03.00.040.0%2.08.00.020.0%8.017.00.032.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%24.00.01.096.0%
Total Gains per Share1.00.00.0100.0%2.01.00.066.7%3.02.00.060.0%8.02.00.080.0%18.07.00.072.0%

Fundamentals of Sigma Pharmaceuticals Ltd

About Sigma Pharmaceuticals Ltd

Sigma Healthcare Limited, together with its subsidiaries, engages in the wholesale distribution of pharmaceutical goods and medical consumables to community pharmacies primarily in Australia. The company operates various aligned pharmacies, including branded pharmacies under the Amcal, Discount Drug Stores, Guardian, and PharmaSave brands. It also provides retail support services to its branded network of pharmacy members; dose administration aid services; and third and fourth-party logistics services to pharmaceutical manufacturers and other supplier partners. The company was founded in 1912 and is headquartered in Clayton, Australia.

Fundamental data was last updated by Penke on 2024-04-05 01:13:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is not making a profit/loss.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is fair priced.

1.1. Profitability of Sigma Pharmaceuticals Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Sigma Pharmaceuticals Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Sigma Pharmaceuticals Ltd to the Medical Distribution industry mean.
  • A Net Profit Margin of 0.1% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Sigma Pharmaceuticals Ltd:

  • The MRQ is 0.1%. The company is not making a profit/loss.
  • The TTM is 0.1%. The company is not making a profit/loss.
Trends
Current periodCompared to+/- 
MRQ0.1%TTM0.1%0.0%
TTM0.1%YOY0.0%+0.1%
TTM0.1%5Y0.2%0.0%
5Y0.2%10Y0.7%-0.6%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1%2.1%-2.0%
TTM0.1%2.1%-2.0%
YOY0.0%2.5%-2.5%
5Y0.2%2.2%-2.0%
10Y0.7%2.3%-1.6%
1.1.2. Return on Assets

Shows how efficient Sigma Pharmaceuticals Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Sigma Pharmaceuticals Ltd to the Medical Distribution industry mean.
  • 0.3% Return on Assets means that Sigma Pharmaceuticals Ltd generated $0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Sigma Pharmaceuticals Ltd:

  • The MRQ is 0.3%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.3%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.3%TTM0.3%0.0%
TTM0.3%YOY0.2%+0.2%
TTM0.3%5Y0.5%-0.2%
5Y0.5%10Y2.4%-1.9%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3%1.6%-1.3%
TTM0.3%1.7%-1.4%
YOY0.2%1.2%-1.0%
5Y0.5%1.1%-0.6%
10Y2.4%1.6%+0.8%
1.1.3. Return on Equity

Shows how efficient Sigma Pharmaceuticals Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Sigma Pharmaceuticals Ltd to the Medical Distribution industry mean.
  • 0.5% Return on Equity means Sigma Pharmaceuticals Ltd generated $0.01 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Sigma Pharmaceuticals Ltd:

  • The MRQ is 0.5%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 0.5%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.5%TTM0.5%0.0%
TTM0.5%YOY0.4%+0.1%
TTM0.5%5Y1.1%-0.5%
5Y1.1%10Y5.1%-4.1%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5%4.3%-3.8%
TTM0.5%3.7%-3.2%
YOY0.4%2.8%-2.4%
5Y1.1%3.5%-2.4%
10Y5.1%3.9%+1.2%

1.2. Operating Efficiency of Sigma Pharmaceuticals Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Sigma Pharmaceuticals Ltd is operating .

  • Measures how much profit Sigma Pharmaceuticals Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Sigma Pharmaceuticals Ltd to the Medical Distribution industry mean.
  • An Operating Margin of -2.2% means the company generated $-0.02  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Sigma Pharmaceuticals Ltd:

  • The MRQ is -2.2%. The company is operating very inefficient. -2
  • The TTM is -2.2%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-2.2%TTM-2.2%0.0%
TTM-2.2%YOY-1.9%-0.3%
TTM-2.2%5Y-2.7%+0.5%
5Y-2.7%10Y-0.3%-2.4%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.2%2.9%-5.1%
TTM-2.2%2.9%-5.1%
YOY-1.9%3.9%-5.8%
5Y-2.7%3.5%-6.2%
10Y-0.3%3.4%-3.7%
1.2.2. Operating Ratio

Measures how efficient Sigma Pharmaceuticals Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Distribution industry mean).
  • An Operation Ratio of 1.02 means that the operating costs are $1.02 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Sigma Pharmaceuticals Ltd:

  • The MRQ is 1.022. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.022. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.022TTM1.0220.000
TTM1.022YOY1.019+0.003
TTM1.0225Y1.027-0.005
5Y1.02710Y1.008+0.019
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0221.642-0.620
TTM1.0221.594-0.572
YOY1.0191.431-0.412
5Y1.0271.365-0.338
10Y1.0081.229-0.221

1.3. Liquidity of Sigma Pharmaceuticals Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Sigma Pharmaceuticals Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Distribution industry mean).
  • A Current Ratio of 2.46 means the company has $2.46 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Sigma Pharmaceuticals Ltd:

  • The MRQ is 2.458. The company is able to pay all its short-term debts. +1
  • The TTM is 2.458. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.458TTM2.4580.000
TTM2.458YOY1.437+1.021
TTM2.4585Y1.636+0.822
5Y1.63610Y1.614+0.022
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ2.4581.389+1.069
TTM2.4581.400+1.058
YOY1.4371.424+0.013
5Y1.6361.411+0.225
10Y1.6141.329+0.285
1.3.2. Quick Ratio

Measures if Sigma Pharmaceuticals Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Sigma Pharmaceuticals Ltd to the Medical Distribution industry mean.
  • A Quick Ratio of 1.82 means the company can pay off $1.82 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Sigma Pharmaceuticals Ltd:

  • The MRQ is 1.822. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.822. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.822TTM1.8220.000
TTM1.822YOY0.742+1.080
TTM1.8225Y0.955+0.867
5Y0.95510Y1.009-0.054
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8220.730+1.092
TTM1.8220.745+1.077
YOY0.7420.798-0.056
5Y0.9550.784+0.171
10Y1.0090.850+0.159

1.4. Solvency of Sigma Pharmaceuticals Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Sigma Pharmaceuticals Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Sigma Pharmaceuticals Ltd to Medical Distribution industry mean.
  • A Debt to Asset Ratio of 0.38 means that Sigma Pharmaceuticals Ltd assets are financed with 37.9% credit (debt) and the remaining percentage (100% - 37.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Sigma Pharmaceuticals Ltd:

  • The MRQ is 0.379. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.379. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.379TTM0.3790.000
TTM0.379YOY0.602-0.224
TTM0.3795Y0.558-0.179
5Y0.55810Y0.550+0.008
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3790.609-0.230
TTM0.3790.606-0.227
YOY0.6020.600+0.002
5Y0.5580.580-0.022
10Y0.5500.586-0.036
1.4.2. Debt to Equity Ratio

Measures if Sigma Pharmaceuticals Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Sigma Pharmaceuticals Ltd to the Medical Distribution industry mean.
  • A Debt to Equity ratio of 61.0% means that company has $0.61 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Sigma Pharmaceuticals Ltd:

  • The MRQ is 0.610. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.610. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.610TTM0.6100.000
TTM0.610YOY1.521-0.911
TTM0.6105Y1.340-0.730
5Y1.34010Y1.287+0.053
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6101.554-0.944
TTM0.6101.554-0.944
YOY1.5211.688-0.167
5Y1.3401.675-0.335
10Y1.2871.759-0.472

2. Market Valuation of Sigma Pharmaceuticals Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Sigma Pharmaceuticals Ltd generates.

  • Above 15 is considered overpriced but always compare Sigma Pharmaceuticals Ltd to the Medical Distribution industry mean.
  • A PE ratio of 374.58 means the investor is paying $374.58 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Sigma Pharmaceuticals Ltd:

  • The EOD is 461.440. Based on the earnings, the company is expensive. -2
  • The MRQ is 374.581. Based on the earnings, the company is expensive. -2
  • The TTM is 374.581. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD461.440MRQ374.581+86.859
MRQ374.581TTM374.5810.000
TTM374.581YOY555.160-180.579
TTM374.5815Y154.353+220.228
5Y154.35310Y90.649+63.704
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD461.44012.427+449.013
MRQ374.58114.424+360.157
TTM374.58115.740+358.841
YOY555.16018.752+536.408
5Y154.35315.472+138.881
10Y90.64919.379+71.270
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Sigma Pharmaceuticals Ltd:

  • The EOD is 55.860. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The MRQ is 45.346. Based on how much money comes from the company's main activities, the company is fair priced.
  • The TTM is 45.346. Based on how much money comes from the company's main activities, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD55.860MRQ45.346+10.515
MRQ45.346TTM45.3460.000
TTM45.346YOY253.631-208.286
TTM45.3465Y68.448-23.102
5Y68.44810Y87.556-19.108
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD55.8607.168+48.692
MRQ45.3466.758+38.588
TTM45.34612.327+33.019
YOY253.6313.478+250.153
5Y68.4483.969+64.479
10Y87.5563.188+84.368
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Sigma Pharmaceuticals Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Distribution industry mean).
  • A PB ratio of 1.94 means the investor is paying $1.94 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Sigma Pharmaceuticals Ltd:

  • The EOD is 2.384. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.936. Based on the equity, the company is underpriced. +1
  • The TTM is 1.936. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.384MRQ1.936+0.449
MRQ1.936TTM1.9360.000
TTM1.936YOY2.104-0.169
TTM1.9365Y1.904+0.031
5Y1.90410Y2.203-0.299
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD2.3840.988+1.396
MRQ1.9361.157+0.779
TTM1.9361.157+0.779
YOY2.1041.208+0.896
5Y1.9041.257+0.647
10Y2.2031.922+0.281
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Sigma Pharmaceuticals Ltd.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Sigma Pharmaceuticals Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.2420.2420%-0.007+103%0.044+451%0.018+1244%
Book Value Per Share--0.5350.5350%0.293+83%0.347+54%0.339+58%
Current Ratio--2.4582.4580%1.437+71%1.636+50%1.614+52%
Debt To Asset Ratio--0.3790.3790%0.602-37%0.558-32%0.550-31%
Debt To Equity Ratio--0.6100.6100%1.521-60%1.340-54%1.287-53%
Dividend Per Share--0.0060.0060%0.010-37%0.010-36%0.019-67%
Eps--0.0030.0030%0.001+149%0.006-52%0.018-85%
Free Cash Flow Per Share--0.0230.0230%0.002+840%0.016+39%0.014+61%
Free Cash Flow To Equity Per Share--0.2040.2040%-0.069+134%0.009+2117%0.010+1865%
Gross Profit Margin---37.400-37.4000%-115.167+208%-21.332-43%-12.236-67%
Intrinsic Value_10Y_max--0.857--------
Intrinsic Value_10Y_min--0.003--------
Intrinsic Value_1Y_max--0.031--------
Intrinsic Value_1Y_min--0.009--------
Intrinsic Value_3Y_max--0.136--------
Intrinsic Value_3Y_min--0.019--------
Intrinsic Value_5Y_max--0.290--------
Intrinsic Value_5Y_min--0.021--------
Market Cap2080634188.800+19%1688985400.3201688985400.3200%1005395077.427+68%1080330545.623+56%1214617123.973+39%
Net Profit Margin--0.0010.0010%0.000+174%0.002-22%0.007-82%
Operating Margin---0.022-0.0220%-0.019-13%-0.027+22%-0.003-87%
Operating Ratio--1.0221.0220%1.019+0%1.0270%1.008+1%
Pb Ratio2.384+19%1.9361.9360%2.104-8%1.904+2%2.203-12%
Pe Ratio461.440+19%374.581374.5810%555.160-33%154.353+143%90.649+313%
Price Per Share1.275+19%1.0351.0350%0.616+68%0.662+56%0.744+39%
Price To Free Cash Flow Ratio55.860+19%45.34645.3460%253.631-82%68.448-34%87.556-48%
Price To Total Gains Ratio5.140+19%4.1724.1720%204.017-98%-6.063+245%20.382-80%
Quick Ratio--1.8221.8220%0.742+146%0.955+91%1.009+81%
Return On Assets--0.0030.0030%0.002+113%0.005-35%0.024-86%
Return On Equity--0.0050.0050%0.004+36%0.011-51%0.051-90%
Total Gains Per Share--0.2480.2480%0.003+8115%0.053+364%0.037+578%
Usd Book Value--560478045.300560478045.3000%306869101.800+83%363574428.840+54%354872998.050+58%
Usd Book Value Change Per Share--0.1550.1550%-0.004+103%0.028+451%0.012+1244%
Usd Book Value Per Share--0.3430.3430%0.188+83%0.223+54%0.217+58%
Usd Dividend Per Share--0.0040.0040%0.006-37%0.006-36%0.012-67%
Usd Eps--0.0020.0020%0.001+149%0.004-52%0.012-85%
Usd Free Cash Flow--23923748.10023923748.1000%2546077.200+840%17164568.280+39%14872906.110+61%
Usd Free Cash Flow Per Share--0.0150.0150%0.002+840%0.011+39%0.009+61%
Usd Free Cash Flow To Equity Per Share--0.1310.1310%-0.044+134%0.006+2117%0.007+1865%
Usd Market Cap1336391339.466+19%1084835322.6261084835322.6260%645765258.231+68%693896309.454+56%780148578.728+39%
Usd Price Per Share0.819+19%0.6650.6650%0.396+68%0.425+56%0.478+39%
Usd Profit--2896130.7002896130.7000%1163205.300+149%3889768.800-26%17876365.140-84%
Usd Revenue--2133757853.4002133757853.4000%2350972152.000-9%2193211068.300-3%2333685418.260-9%
Usd Total Gains Per Share--0.1590.1590%0.002+8115%0.034+364%0.023+578%
 EOD+4 -4MRQTTM+0 -0YOY+29 -75Y+23 -1310Y+21 -15

4.2. Fundamental Score

Let's check the fundamental score of Sigma Pharmaceuticals Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15461.440
Price to Book Ratio (EOD)Between0-12.384
Net Profit Margin (MRQ)Greater than00.001
Operating Margin (MRQ)Greater than0-0.022
Quick Ratio (MRQ)Greater than11.822
Current Ratio (MRQ)Greater than12.458
Debt to Asset Ratio (MRQ)Less than10.379
Debt to Equity Ratio (MRQ)Less than10.610
Return on Equity (MRQ)Greater than0.150.005
Return on Assets (MRQ)Greater than0.050.003
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of Sigma Pharmaceuticals Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5056.728
Ma 20Greater thanMa 501.252
Ma 50Greater thanMa 1001.182
Ma 100Greater thanMa 2001.043
OpenGreater thanClose1.295
Total5/5 (100.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2020-01-312021-01-312022-01-312023-01-312024-01-31
Net Debt  195,9753,128199,10393,184292,287-81,952210,335-430,200-219,865
Long-term Assets Other  -102,9600-102,9600-102,9607,739-95,22196,4121,191



Latest Balance Sheet

Balance Sheet of 2024-01-31. Currency in AUD. All numbers in thousands.

Summary
Total Assets1,404,133
Total Liabilities531,522
Total Stockholder Equity870,770
 As reported
Total Liabilities 531,522
Total Stockholder Equity+ 870,770
Total Assets = 1,404,133

Assets

Total Assets1,404,133
Total Current Assets912,500
Long-term Assets491,633
Total Current Assets
Cash And Cash Equivalents 356,496
Net Receivables 319,965
Inventory 221,129
Other Current Assets 14,910
Total Current Assets  (as reported)912,500
Total Current Assets  (calculated)912,500
+/-0
Long-term Assets
Property Plant Equipment 271,776
Goodwill 89,064
Long Term Investments 13,622
Intangible Assets 19,998
Long-term Assets Other 1,191
Long-term Assets  (as reported)491,633
Long-term Assets  (calculated)395,651
+/- 95,982

Liabilities & Shareholders' Equity

Total Current Liabilities371,280
Long-term Liabilities160,242
Total Stockholder Equity870,770
Total Current Liabilities
Short-term Debt 9,789
Accounts payable 303,356
Other Current Liabilities 57,994
Total Current Liabilities  (as reported)371,280
Total Current Liabilities  (calculated)371,139
+/- 141
Long-term Liabilities
Capital Lease Obligations 136,631
Long-term Liabilities  (as reported)160,242
Long-term Liabilities  (calculated)136,631
+/- 23,611
Total Stockholder Equity
Common Stock1,682,372
Retained Earnings -769,176
Accumulated Other Comprehensive Income 2,923
Other Stockholders Equity -45,349
Total Stockholder Equity (as reported)870,770
Total Stockholder Equity (calculated)870,770
+/-0
Other
Capital Stock1,637,023
Cash and Short Term Investments 356,496
Common Stock Shares Outstanding 1,063,315
Current Deferred Revenue141
Liabilities and Stockholders Equity 1,404,133
Net Debt -219,865
Net Invested Capital 870,770
Net Working Capital 541,220
Property Plant and Equipment Gross 364,315
Short Long Term Debt Total 136,631



Balance Sheet

Currency in AUD. All numbers in thousands.

 Trend2024-01-312023-01-312022-01-312021-01-312020-01-312019-01-312018-01-312017-01-312016-01-312015-01-312014-01-312013-01-312012-01-312011-01-312010-01-312009-01-312008-01-312007-01-312006-01-312005-01-312004-01-312003-01-312002-01-312001-01-312000-01-31
> Total Assets 
545,802
609,041
56,455
64,190
81,090
98,952
1,960,846
2,068,608
2,066,902
2,201,464
1,926,046
1,552,998
1,081,403
1,056,171
945,169
1,055,663
1,108,651
1,118,882
1,308,239
1,383,854
1,229,429
1,219,361
1,275,431
1,201,609
1,404,133
1,404,1331,201,6091,275,4311,219,3611,229,4291,383,8541,308,2391,118,8821,108,6511,055,663945,1691,056,1711,081,4031,552,9981,926,0462,201,4642,066,9022,068,6081,960,84698,95281,09064,19056,455609,041545,802
   > Total Current Assets 
0
0
52,508
59,474
74,431
88,108
575,514
631,148
631,929
643,998
715,876
1,452,391
941,561
951,388
855,998
879,872
929,368
918,725
1,033,418
1,004,209
735,945
702,196
761,635
685,848
912,500
912,500685,848761,635702,196735,9451,004,2091,033,418918,725929,368879,872855,998951,388941,5611,452,391715,876643,998631,929631,148575,51488,10874,43159,47452,50800
       Cash And Cash Equivalents 
22,765
10,762
3,164
2,329
7,634
721
36,195
49,802
47,031
49,986
14,418
556,904
148,601
112,692
67,468
34,284
17,407
24,403
82,249
72,610
104,232
16,128
31,145
16,650
356,496
356,49616,65031,14516,128104,23272,61082,24924,40317,40734,28467,468112,692148,601556,90414,41849,98647,03149,80236,1957217,6342,3293,16410,76222,765
       Short-term Investments 
0
0
0
0
0
0
0
2,127
3,439
0
55,448
666
0
0
0
0
0
0
0
0
0
0
14
0
0
0014000000000066655,44803,4392,1270000000
       Net Receivables 
174,047
193,236
30,134
32,592
48,999
61,858
256,206
210,982
229,250
258,496
346,002
648,799
576,056
566,219
557,401
589,957
618,248
566,895
577,870
577,367
301,531
327,304
358,749
337,450
319,965
319,965337,450358,749327,304301,531577,367577,870566,895618,248589,957557,401566,219576,056648,799346,002258,496229,250210,982256,20661,85848,99932,59230,134193,236174,047
       Other Current Assets 
4,561
5,672
289
283
406
372
9,405
8,132
6,582
10,112
11,538
21,162
2,687
17,467
8,737
4,246
5,087
5,427
19,318
10,960
14,689
9,626
50,101
6,897
14,910
14,9106,89750,1019,62614,68910,96019,3185,4275,0874,2468,73717,4672,68721,16211,53810,1126,5828,1329,4053724062832895,6724,561
   > Long-term Assets 
0
0
3,947
4,716
6,659
10,844
1,385,332
1,437,460
1,434,973
1,557,466
1,210,170
100,607
139,842
104,783
89,171
175,791
179,283
200,157
274,821
379,645
493,484
517,165
513,796
515,761
491,633
491,633515,761513,796517,165493,484379,645274,821200,157179,283175,79189,171104,783139,842100,6071,210,1701,557,4661,434,9731,437,4601,385,33210,8446,6594,7163,94700
       Property Plant Equipment 
86,174
98,363
1,969
2,379
4,346
7,928
129,606
189,660
221,980
202,869
246,058
52,538
68,602
73,556
52,887
57,716
58,540
77,870
128,515
224,141
299,355
288,289
281,564
290,923
271,776
271,776290,923281,564288,289299,355224,141128,51577,87058,54057,71652,88773,55668,60252,538246,058202,869221,980189,660129,6067,9284,3462,3791,96998,36386,174
       Goodwill 
0
15,405
1,619
1,507
1,178
849
880,369
881,217
881,217
960,817
538,582
0
0
0
0
75,217
79,176
80,789
93,084
93,084
102,960
102,960
102,960
95,221
89,064
89,06495,221102,960102,960102,96093,08493,08480,78979,17675,2170000538,582960,817881,217881,217880,3698491,1781,5071,61915,4050
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,934
650
1,458
2,292
4,567
14,221
15,303
17,632
16,077
13,622
13,62216,07717,63215,30314,2214,5672,2921,4586507,934000000000000000
       Intangible Assets 
99,851
90,913
86,282
1,507
1,178
233,489
346,112
328,617
294,479
351,326
328,972
15,030
14,597
14,237
22,553
23,044
22,362
21,905
32,287
32,430
135,367
128,707
128,050
118,243
19,998
19,998118,243128,050128,707135,36732,43032,28721,90522,36223,04422,55314,23714,59715,030328,972351,326294,479328,617346,112233,4891,1781,50786,28290,91399,851
       Long-term Assets Other 
0
0
0
1,026
3,129
0
0
0
1,524
123
46,343
13,724
37,692
9,903
6,605
4,738
9,185
3,459
868
6,306
-102,960
-102,960
-102,960
-95,221
1,191
1,191-95,221-102,960-102,960-102,9606,3068683,4599,1854,7386,6059,90337,69213,72446,3431231,5240003,1291,026000
> Total Liabilities 
291,293
358,397
45,638
49,463
53,825
64,844
691,679
724,152
866,249
1,003,532
859,092
720,079
398,876
445,365
366,340
482,662
554,997
580,295
792,980
869,574
752,689
705,002
786,653
723,843
531,522
531,522723,843786,653705,002752,689869,574792,980580,295554,997482,662366,340445,365398,876720,079859,0921,003,532866,249724,152691,67964,84453,82549,46345,638358,397291,293
   > Total Current Liabilities 
285,130
336,418
40,316
44,142
46,560
53,649
525,758
333,198
348,001
668,080
761,595
710,156
391,361
443,898
364,358
478,320
549,076
574,607
784,507
663,315
575,951
523,657
457,614
477,357
371,280
371,280477,357457,614523,657575,951663,315784,507574,607549,076478,320364,358443,898391,361710,156761,595668,080348,001333,198525,75853,64946,56044,14240,316336,418285,130
       Short-term Debt 
0
0
0
7
7,507
5,008
162,855
0
33,776
211,697
322,200
358,577
35,000
30,000
0
291
73,025
32,143
195,014
115,003
142,967
75,413
25,693
12,944
9,789
9,78912,94425,69375,413142,967115,003195,01432,14373,025291030,00035,000358,577322,200211,69733,7760162,8555,0087,5077000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
291
11
32,143
195,014
115,003
135,022
66,379
15,375
3,681
0
03,68115,37566,379135,022115,003195,01432,14311291000000000000000
       Accounts payable 
234,099
288,771
186,026
211,068
217,175
240,760
304,174
297,324
269,227
373,083
353,876
251,284
311,554
375,775
327,491
373,883
406,657
475,285
526,511
492,804
359,988
365,469
352,273
406,012
303,356
303,356406,012352,273365,469359,988492,804526,511475,285406,657373,883327,491375,775311,554251,284353,876373,083269,227297,324304,174240,760217,175211,068186,026288,771234,099
       Other Current Liabilities 
24,355
22,507
3,759
8,879
6,237
9,679
58,729
35,874
44,998
83,300
83,598
100,274
44,304
37,982
36,615
103,024
66,613
64,959
59,823
53,021
71,572
82,319
77,762
57,445
57,994
57,99457,44577,76282,31971,57253,02159,82364,95966,613103,02436,61537,98244,304100,27483,59883,30044,99835,87458,7299,6796,2378,8793,75922,50724,355
   > Long-term Liabilities 
0
0
5,322
5,321
7,265
11,195
165,921
390,954
518,248
335,452
97,497
9,923
7,515
1,467
1,982
4,342
5,921
5,688
8,473
206,259
176,738
181,345
329,039
246,486
160,242
160,242246,486329,039181,345176,738206,2598,4735,6885,9214,3421,9821,4677,5159,92397,497335,452518,248390,954165,92111,1957,2655,3215,32200
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,028
1,016
788
200,787
157,240
139,818
297,739
214,041
0
0214,041297,739139,818157,240200,7877881,0161,0280000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
-7
-7,507
-5,008
-162,855
0
-33,776
-211,697
-322,200
-358,577
-35,000
-30,000
0
-291
-73,025
-32,143
-195,014
-115,003
-92,970
73,439
117,364
130,360
126,842
126,842130,360117,36473,439-92,970-115,003-195,014-32,143-73,025-2910-30,000-35,000-358,577-322,200-211,697-33,7760-162,855-5,008-7,507-7000
> Total Stockholder Equity
254,509
250,644
10,817
14,727
27,265
34,108
1,269,167
1,344,456
1,200,653
1,197,932
1,066,954
832,919
682,527
610,806
578,829
573,002
552,152
536,763
513,108
513,254
475,954
513,672
487,188
475,918
870,770
870,770475,918487,188513,672475,954513,254513,108536,763552,152573,002578,829610,806682,527832,9191,066,9541,197,9321,200,6531,344,4561,269,16734,10827,26514,72710,817250,644254,509
   Common Stock
216,190
216,139
3,501
3,676
3,677
3,678
1,200,257
1,204,722
1,074,470
1,083,578
1,367,566
1,367,647
1,365,258
1,337,226
1,294,414
1,255,466
1,238,394
1,226,904
1,200,755
1,207,794
1,286,194
1,286,144
1,286,144
1,286,144
1,682,372
1,682,3721,286,1441,286,1441,286,1441,286,1941,207,7941,200,7551,226,9041,238,3941,255,4661,294,4141,337,2261,365,2581,367,6471,367,5661,083,5781,074,4701,204,7221,200,2573,6783,6773,6763,501216,139216,190
   Retained Earnings 
23,843
24,771
7,316
11,051
23,588
30,430
64,279
132,125
133,735
154,197
-303,740
-548,354
-698,766
-740,931
-733,122
-702,850
-696,890
-700,693
-701,919
-708,372
-753,803
-711,469
-741,134
-761,587
-769,176
-769,176-761,587-741,134-711,469-753,803-708,372-701,919-700,693-696,890-702,850-733,122-740,931-698,766-548,354-303,740154,197133,735132,12564,27930,43023,58811,0517,31624,77123,843
   Capital Surplus 0000000000000000000000000
   Treasury Stock00000-78,450-86,382-72,252-65,752-59,822-41,651-31,248-17,246000000000000
   Other Stockholders Equity 
0
0
2,459
0
0
0
0
0
0
0
0
0
0
0
17,537
20,386
226
10,552
14,272
13,832
-69,638
-66,231
-60,689
-51,682
-45,349
-45,349-51,682-60,689-66,231-69,63813,83214,27210,55222620,38617,537000000000002,45900



Balance Sheet

Currency in AUD. All numbers in thousands.